Jazz Pharmaceuticals PLC 2024 SR
The report highlights Jazz Pharmaceuticals' progress in 2024 across its four CSSI pillars: Patients, People, Community, and Planet. Key achievements include securing FDA approval for a Biliary Tract Cancer treatment, advancing patient-centricity through the Patient Centricity Advisory Council, and achieving 100% renewable electricity at internal manufacturing sites. The company also prioritized preparedness for the EU's Corporate Sustainability Reporting Directive (CSRD) and conducted a Double Materiality Assessment. Additionally, Jazz fostered an inclusive culture with 37% employee participation in resource teams and contributed over 300 volunteer hours to combat poverty through Life Science Cares.
Company: Jazz Pharmaceuticals PLC
Sector: Health Care
Country: Ireland
Year: 2024
Type: SR
Pages: 42
Jazz Pharmaceuticals PLC
Corporate Sustainability And Social Impact Report
The report highlights Jazz Pharmaceuticals' progress in 2024 across its four CSSI pillars: Patients, People, Community, and Planet. Key achievements include securing FDA approval for a Biliary Tract Cancer treatment, advancing patient-centricity through the Patient Centricity Advisory Council, and achieving 100% renewable electricity at internal manufacturing sites. The company also prioritized preparedness for the EU's Corporate Sustainability Reporting Directive (CSRD) and conducted a Double Materiality Assessment. Additionally, Jazz fostered an inclusive culture with 37% employee participation in resource teams and contributed over 300 volunteer hours to combat poverty through Life Science Cares.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Employees